Short answer · Medically reviewed summary · Last updated: 2026-04-07
Multiple epiphyseal dysplasia (MED) was first formally described in the medical literature by Dr. H.J.
Multiple epiphyseal dysplasia (MED) was first formally described in the medical literature by Dr. H.J. Barrington Fairbank in 1935, who distinguished it from other skeletal dysplasias by identifying the characteristic delayed and irregular ossification of the epiphyses. Since its discovery, our understanding of Multiple epiphyseal dysplasia has shifted from a clinical diagnosis based solely on radiographic appearance to a precise molecular diagnosis driven by the identification of specific gene mutations.
While various forms of skeletal irregularities were documented in the late 19th century, the clinical entity now known as Multiple epiphyseal dysplasia was clearly defined by the British orthopedic surgeon Sir H.J. Barrington Fairbank in 1935. Fairbank recognized that patients presented with a specific pattern of joint pain and gait abnormalities that did not fit the criteria for other known dwarfism syndromes. For decades, the diagnosis of Multiple epiphyseal dysplasia remained purely radiological, relying on X-ray evidence of flattened or fragmented epiphyses (the ends of long bones) to differentiate it from other osteochondrodysplasias.
The history of this condition is a transition from observation to genetic mapping. In the mid-20th century, clinicians struggled with the heterogeneity of the disease, often confusing it with milder forms of pseudoachondroplasia. The modern era began in the 1990s when researchers identified the first genetic culprits. We now know that Multiple epiphyseal dysplasia is not a single disease but a group of genetically distinct disorders involving the cartilage matrix proteins.
The most significant leap in understanding occurred with the discovery of the specific genes responsible for the condition. The following milestones highlight how technology refined our knowledge:
Historically, patients with Multiple epiphyseal dysplasia were often misdiagnosed with early-onset osteoarthritis or "growing pains" in childhood. Because the condition often presents with subtle physical signs—such as a waddling gait or mild short stature—it was frequently overlooked or dismissed. The development of high-resolution genetic sequencing has effectively corrected these misconceptions, allowing for early diagnosis and preventing unnecessary or incorrect interventions.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.